• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

University of Cambridge

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune diseaseT-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
    T-Therapeutics
    13 Nov 2025

    T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease

    T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.

    NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horsesNoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
    NoBACZ
    30 Sept 2025

    NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses

    NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.

    Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal VenturesRobin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures
    Robin AI
    14 Nov 2024

    Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures

    Robin AI develops legal AI software for large enterprises that analyses, summarises and extracts insights from complex contracts and documents, supporting due diligence, compliance and incident response at scale.

University of Cambridge
    • Life Sciences
    • Agriculture
    • Legal
  • 2(12 months)
  • cam.ac.uk
  • Update Information

More venture news

  • Origin raises a £22m Series A+ led by Notion Capital for enterprise benefits intelligence platform
    Origin
    25 Mar 2026

    Origin raises a £22m Series A+ led by Notion Capital for enterprise benefits intelligence platform

    ExtensionHR
  • Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    ExtensionHealth
  • Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
    Centauri Therapeutics
    24 Feb 2026

    Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy

    ExtensionLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn